[1]
|
Roth, G.A., Mensah, G.A., Johnson, C.O., et al. (2020) Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study. Journal of the American College of Cardiology, 76, 2982-3021.
|
[2]
|
Wang, L., Zhou, B., Zhao, Z., Yang, L., Zhang, M., Jiang, Y., et al. (2021) Body-Mass Index and Obesity in Urban and Rural China: Findings from Consecutive Nationally Representative Surveys during 2004-18. The Lancet, 398, 53-63. https://doi.org/10.1016/s0140-6736(21)00798-4
|
[3]
|
Xia, C., Li, R., Zhang, S., Gong, L., Ren, W., Wang, Z., et al. (2012) Lipid Accumulation Product Is a Powerful Index for Recognizing Insulin Resistance in Non-Diabetic Individuals. European Journal of Clinical Nutrition, 66, 1035-1038. https://doi.org/10.1038/ejcn.2012.83
|
[4]
|
Gast, K.B., Tjeerdema, N., Stijnen, T., Smit, J.W.A. and Dekkers, O.M. (2012) Insulin Resistance and Risk of Incident Cardiovascular Events in Adults without Diabetes: Meta-Analysis. PLOS ONE, 7, e52036. https://doi.org/10.1371/journal.pone.0052036
|
[5]
|
Guo, S. (2013) Insulin Signaling, Resistance, and Metabolic Syndrome: Insights from Mouse Models into Disease Mechanisms. Journal of Endocrinology, 220, T1-T23. https://doi.org/10.1530/joe-13-0327
|
[6]
|
Cheng, Y., Tsao, Y., Tzeng, I., Chuang, H., Li, W., Tung, T., et al. (2017) Medicine, 96, e8126. https://doi.org/10.1097/md.0000000000008126
|
[7]
|
Balsan, G.A., Vieira, J.L.d.C., Oliveira, A.M.d. and Portal, V.L. (2015) Relationship between Adiponectin, Obesity and Insulin Resistance. Revista da Associação Médica Brasileira, 61, 72-80. https://doi.org/10.1590/1806-9282.61.01.072
|
[8]
|
Sasaki, R., Yano, Y., Yasuma, T., Onishi, Y., Suzuki, T., Maruyama-Furuta, N., et al. (2016) Association of Waist Circumference and Body Fat Weight with Insulin Resistance in Male Subjects with Normal Body Mass Index and Normal Glucose Tolerance. Internal Medicine, 55, 1425-1432. https://doi.org/10.2169/internalmedicine.55.4100
|
[9]
|
Premanath, M., Basavanagowdappa, H., Mahesh, M. and Suresh, M. (2014) Correlation of Abdominal Adiposity with Components of Metabolic Syndrome, Anthropometric Parameters and Insulin Resistance, in Obese and Non Obese, Diabetics and Non Diabetics: A Cross Sectional Observational Study. (Mysore Visceral Adiposity in Diabetes Study). Indian Journal of Endocrinology and Metabolism, 18, 676-682. https://doi.org/10.4103/2230-8210.139231
|
[10]
|
Patel, P. and Abate, N. (2013) Body Fat Distribution and Insulin Resistance. Nutrients, 5, 2019-2027. https://doi.org/10.3390/nu5062019
|
[11]
|
Feng, J., He, S. and Chen, X. (2019) Body Adiposity Index and Body Roundness Index in Identifying Insulin Resistance among Adults without Diabetes. The American Journal of the Medical Sciences, 357, 116-123. https://doi.org/10.1016/j.amjms.2018.11.006
|
[12]
|
Xia, C., Li, R., Zhang, S., Gong, L., Ren, W., Wang, Z., et al. (2012) Lipid Accumulation Product Is a Powerful Index for Recognizing Insulin Resistance in Non-Diabetic Individuals. European Journal of Clinical Nutrition, 66, 1035-1038. https://doi.org/10.1038/ejcn.2012.83
|
[13]
|
Er, L., Wu, S., Chou, H., Hsu, L., Teng, M., Sun, Y., et al. (2016) Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals. PLOS ONE, 11, e0149731. https://doi.org/10.1371/journal.pone.0149731
|
[14]
|
Azcutia, V., Abu-Taha, M., Romacho, T., Vázquez-Bella, M., Matesanz, N., Luscinskas, F.W., et al. (2010) Inflammation Determines the Pro-Adhesive Properties of High Extracellular D-Glucose in Human Endothelial Cells in Vitro and Rat Microvessels in Vivo. PLOS ONE, 5, e10091. https://doi.org/10.1371/journal.pone.0010091
|
[15]
|
Moore, K.J. and Tabas, I. (2011) Macrophages in the Pathogenesis of Atherosclerosis. Cell, 145, 341-355. https://doi.org/10.1016/j.cell.2011.04.005
|
[16]
|
Bornfeldt, K.E. and Tabas, I. (2011) Insulin Resistance, Hyperglycemia, and Atherosclerosis. Cell Metabolism, 14, 575-585. https://doi.org/10.1016/j.cmet.2011.07.015
|
[17]
|
Greenland, P. (2003) Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events. Journal of the American Medical Association, 290, 891-897. https://doi.org/10.1001/jama.290.7.891
|
[18]
|
Canto, J.G., Kiefe, C.I., Rogers, W.J., Peterson, E.D., Frederick, P.D., French, W.J., et al. (2011) Number of Coronary Heart Disease Risk Factors and Mortality in Patients with First Myocardial Infarction. Journal of the American Medical Association, 306, 2120-2127. https://doi.org/10.1001/jama.2011.1654
|
[19]
|
Tao, L., Xu, J., Wang, T., Hua, F. and Li, J. (2022) Triglyceride-Glucose Index as a Marker in Cardiovascular Diseases: Landscape and Limitations. Cardiovascular Diabetology, 21, Article 68.
|
[20]
|
Hill, M.A., Yang, Y., Zhang, L., Sun, Z., Jia, G., Parrish, A.R., et al. (2021) Insulin Resistance, Cardiovascular Stiffening and Cardiovascular Disease. Metabolism, 119, Article 154766. https://doi.org/10.1016/j.metabol.2021.154766
|
[21]
|
DeFronzo, R.A. (2010) Insulin Resistance, Lipotoxicity, Type 2 Diabetes and Atherosclerosis: The Missing Links. The Claude Bernard Lecture 2009. Diabetologia, 53, 1270-1287. https://doi.org/10.1007/s00125-010-1684-1
|
[22]
|
Huang, Y., Huang, J., Lin, C., Chien, H., Lin, Y., Wang, C., et al. (2021) Comparison of Innovative and Traditional Cardiometabolic Indices in Estimating Atherosclerotic Cardiovascular Disease Risk in Adults. Diagnostics, 11, Article 603. https://doi.org/10.3390/diagnostics11040603
|
[23]
|
Reho, J.J. and Rahmouni, K. (2017) Oxidative and Inflammatory Signals in Obesity-Associated Vascular Abnormalities. Clinical Science, 131, 1689-1700. https://doi.org/10.1042/cs20170219
|
[24]
|
Van Gaal, L.F., Mertens, I.L. and De Block, C.E. (2006) Mechanisms Linking Obesity with Cardiovascular Disease. Nature, 444, 875-880. https://doi.org/10.1038/nature05487
|
[25]
|
Van de Voorde, J., Pauwels, B., Boydens, C. and Decaluwé, K. (2013) Adipocytokines in Relation to Cardiovascular Disease. Metabolism, 62, 1513-1521. https://doi.org/10.1016/j.metabol.2013.06.004
|
[26]
|
Vecsernyes, M., Szokol, M., Bombicz, M., Priksz, D., Gesztelyi, R., Fulop, G.A., et al. (2017) Alpha-Melanocyte-Stimulating Hormone Induces Vasodilation and Exerts Cardioprotection through the Heme-Oxygenase Pathway in Rat Hearts. Journal of Cardiovascular Pharmacology, 69, 286-297. https://doi.org/10.1097/fjc.0000000000000472
|
[27]
|
Feigin, V.L., Krishnamurthi, R.V., Parmar, P., Norrving, B., Mensah, G.A., Bennett, D.A., et al. (2015) Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study. Neuroepidemiology, 45, 161-176. https://doi.org/10.1159/000441085
|
[28]
|
Wang, W., Jiang, B., Sun, H., Ru, X., Sun, D., Wang, L., et al. (2017) Prevalence, Incidence, and Mortality of Stroke in China. Circulation, 135, 759-771. https://doi.org/10.1161/circulationaha.116.025250
|
[29]
|
Guan, T., Ma, J., Li, M., Xue, T., Lan, Z., Guo, J., et al. (2017) Rapid Transitions in the Epidemiology of Stroke and Its Risk Factors in China from 2002 to 2013. Neurology, 89, 53-61. https://doi.org/10.1212/wnl.0000000000004056
|
[30]
|
O’Donnell, M.J., Chin, S.L., Rangarajan, S., Xavier, D., Liu, L., Zhang, H., et al. (2016) Global and Regional Effects of Potentially Modifiable Risk Factors Associated with Acute Stroke in 32 Countries (INTERSTROKE): A Case-Control Study. The Lancet, 388, 761-775. https://doi.org/10.1016/s0140-6736(16)30506-2
|
[31]
|
Pluta, R.M. (2010) Insulin Resistance and Risk of Ischemic Stroke Among Nondiabetic Individuals from the Northern Manhattan Study. The journal of the American Medical Association, 304, Article2575.
|
[32]
|
Du, Z., Xing, L., Lin, M. and Sun, Y. (2020) Estimate of Prevalent Ischemic Stroke from Triglyceride Glucose-Body Mass Index in the General Population. BMC Cardiovascular Disorders, 20, Article No. 483. https://doi.org/10.1186/s12872-020-01768-8
|
[33]
|
Kotchen, T.A., Grim, C.E., Kotchen, J.M., Krishnaswami, S., Yang, H., Hoffmann, R.G., et al. (2008) Altered Relationship of Blood Pressure to Adiposity in Hypertension. American Journal of Hypertension, 21, 284-289. https://doi.org/10.1038/ajh.2007.48
|
[34]
|
Fukuda, N., Satoh, C., Hu, W., Nakayama, M., Kishioka, H. and Kanmatsuse, K. (2001) Endogenous Angiotensin II Suppresses Insulin Signaling in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats. Journal of Hypertension, 19, 1651-1658. https://doi.org/10.1097/00004872-200109000-00018
|
[35]
|
Shimamoto, K., Ura, N., Nakagawa, M., Higashiura, K., Takizawa, H., Miyazaki, Y., et al. (1996) The Mechanisms of the Improvement of Insulin Sensitivity by Angiotensin Converting Enzyme Inhibitor. Clinical and Experimental Hypertension, 18, 257-266. https://doi.org/10.3109/10641969609081768
|
[36]
|
Higashiura, K., Ura, N., Miyazaki, Y. and Shimamoto, K. (1999) Effect of an Angiotensin II Receptor Antagonist, Candesartan, on Insulin Resistance and Pressor Mechanisms in Essential Hypertension. Journal of Human Hypertension, 13, S71-S74. https://doi.org/10.1038/sj.jhh.1000748
|
[37]
|
Zeng, Z.Y., Liu, S.X., Xu, H., Xu, X., Liu, X.Z. and Zhao, X.X. (2020) Association of Triglyceride Glucose Index and Its Combination of Obesity Indices with Prehypertension in Lean Individuals: A Cross-Sectional Study of Chinese Adults. The Journal of Clinical Hypertension, 22, 1025-1032. https://doi.org/10.1111/jch.13878
|
[38]
|
Chalasani, N., Younossi, Z., Lavine, J.E., Charlton, M., Cusi, K., Rinella, M., et al. (2017) The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology, 67, 328-357. https://doi.org/10.1002/hep.29367
|
[39]
|
Fujii, H. and Kawada, N. (2020) The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences, 21, Article 3863. https://doi.org/10.3390/ijms21113863
|
[40]
|
Zhang, S., Du, T., Li, M., Jia, J., Lu, H., Lin, X., et al. (2017) Triglyceride Glucose-Body Mass Index Is Effective in Identifying Nonalcoholic Fatty Liver Disease in Nonobese Subjects. Medicine, 96, e7041. https://doi.org/10.1097/md.0000000000007041
|
[41]
|
Dincer, H.E., Dincer, A.P. and Levinson, D.J. (2002) Asymptomatic Hyperuricemia: To Treat or Not to Treat. Cleveland Clinic Journal of Medicine, 69, 594-594. https://doi.org/10.3949/ccjm.69.8.594
|
[42]
|
Maloberti, A., Vanoli, J., Finotto, A., Bombelli, M., Facchetti, R., Redon, P., et al. (2022) Uric Acid Relationships with Lipid Profile and Adiposity Indices: Impact of Different Hyperuricemic Thresholds. The Journal of Clinical Hypertension, 25, 78-85. https://doi.org/10.1111/jch.14613
|
[43]
|
Yanai, H., Adachi, H., Hakoshima, M. and Katsuyama, H. (2021) Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease. International Journal of Molecular Sciences, 22, Article 9221. https://doi.org/10.3390/ijms22179221
|
[44]
|
Seifi, N., Nosrati, M., Koochackpoor, G., Aghasizadeh, M., Bahari, H., Namdar, H.B., et al. (2024) The Association between Hyperuricemia and Insulin Resistance Surrogates, Dietary-and Lifestyle Insulin Resistance Indices in an Iranian Population: Mashad Cohort Study. Nutrition Journal, 23, Article No. 5. https://doi.org/10.1186/s12937-023-00904-2
|
[45]
|
Wang, Y.Y., Li, L., Cui, J., et al. (2020) Associations between Anthropometric Parameters (Body Mass Index, Waist Circumference and Waist to Hip Ratio) and Newly Diagnosed Hyperuricemia in Adults in Qingdao, China: A Cross-Sectional Study. Asia Pacific Journal of Clinical Nutrition, 29, 763-770.
|
[46]
|
Choi, H.K., Atkinson, K., Karlson, E.W. and Curhan, G. (2005) Obesity, Weight Change, Hypertension, Diuretic Use, and Risk of Gout in Men. Archives of Internal Medicine, 165, Article 742. https://doi.org/10.1001/archinte.165.7.742
|
[47]
|
Alfa-Wali, M., Sharma, A., Boniface, S., Tekkis, P., Hackshaw, A. and Antoniou, A. (2012) PD-0011 Metabolic Syndrome (METS) and Risk of Colorectal Cancer (CRC), a Systematic Review and Meta-Analysis. Annals of Oncology, 23, iv22-iv23. https://doi.org/10.1016/s0923-7534(19)66505-1
|
[48]
|
Li, Y., You, A., Tomlinson, B., Yue, L., Zhao, K., Fan, H., et al. (2021) Insulin Resistance Surrogates Predict Hypertension Plus Hyperuricemia. Journal of Diabetes Investigation, 12, 2046-2053. https://doi.org/10.1111/jdi.13573
|
[49]
|
Bhole, V., Choi, J.W.J., Woo Kim, S., de Vera, M. and Choi, H. (2010) Serum Uric Acid Levels and the Risk of Type 2 Diabetes: A Prospective Study. The American Journal of Medicine, 123, 957-961. https://doi.org/10.1016/j.amjmed.2010.03.027
|
[50]
|
Bandaru, P. and Shankar, A. (2011) Association between Serum Uric Acid Levels and Diabetes Mellitus. International Journal of Endocrinology, 2011, 1-6. https://doi.org/10.1155/2011/604715
|
[51]
|
Vadakedath, S. and Kandi, V. (2018) Probable Potential Role of Urate Transporter Genes in the Development of Metabolic Disorders. Cureus, 10, e2382. https://doi.org/10.7759/cureus.2382
|
[52]
|
Fotouhi, A., Ebrahimi, H., Emamian, M., Khosravi, A. and Hashemi, H. (2019) Comparison of the Accuracy of Three Diagnostic Criteria and Estimating the Prevalence of Metabolic Syndrome: A Latent Class Analysis. Journal of Research in Medical Sciences, 24, 108. https://doi.org/10.4103/jrms.jrms_858_18
|
[53]
|
Gallagher, E.J., LeRoith, D. and Karnieli, E. (2010) Insulin Resistance in Obesity as the Underlying Cause for the Metabolic Syndrome. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 77, 511-523. https://doi.org/10.1002/msj.20212
|
[54]
|
Raimi, T.H., Dele-Ojo, B.F., Dada, S.A., Fadare, J.O., Ajayi, D.D., Ajayi, E.A., et al. (2021) Triglyceride-Glucose Index and Related Parameters Predicted Metabolic Syndrome in Nigerians. Metabolic Syndrome and Related Disorders, 19, 76-82. https://doi.org/10.1089/met.2020.0092
|
[55]
|
Alberti, K.G.M.M. and Zimmet, P.Z. (1998) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Provisional Report of a WHO Consultation. Diabetic Medicine, 15, 539-553. https://doi.org/10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
|